Twist Bioscience Corporation (TWST)
USD 36.93
(-3.95%)
USD 36.93
(-3.95%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -176.7 Million USD | -1.47% |
| 2023 | -174.15 Million USD | 21.79% |
| 2022 | -191.55 Million USD | -60.22% |
| 2021 | -143.91 Million USD | -32.63% |
| 2020 | -132.08 Million USD | -9.6% |
| 2019 | -99.77 Million USD | -65.87% |
| 2018 | -63.95 Million USD | -20.43% |
| 2017 | -53.1 Million USD | -35.77% |
| 2016 | -39.11 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -34.71 Million USD | 8.55% |
| 2024 Q2 | -40.58 Million USD | -6.14% |
| 2024 Q3 | -35.69 Million USD | -109.19% |
| 2023 FY | - USD | 21.79% |
| 2023 Q4 | -42.96 Million USD | 3.84% |
| 2023 Q2 | -59.67 Million USD | -30.06% |
| 2023 Q1 | -45.88 Million USD | 18.9% |
| 2023 Q3 | -44.68 Million USD | 25.12% |
| 2022 Q3 | -64.89 Million USD | -3.28% |
| 2022 Q4 | -56.57 Million USD | 12.82% |
| 2022 FY | - USD | -60.22% |
| 2022 Q1 | -58.76 Million USD | -35.92% |
| 2022 Q2 | -62.83 Million USD | -6.92% |
| 2021 FY | - USD | -32.63% |
| 2021 Q4 | -43.23 Million USD | -6.87% |
| 2021 Q1 | -32.73 Million USD | -36.9% |
| 2021 Q2 | -35.29 Million USD | -7.83% |
| 2021 Q3 | -40.45 Million USD | -14.61% |
| 2020 Q2 | -31.49 Million USD | 4.14% |
| 2020 FY | - USD | -9.6% |
| 2020 Q1 | -32.85 Million USD | -6.73% |
| 2020 Q4 | -23.91 Million USD | 14.62% |
| 2020 Q3 | -28 Million USD | 11.07% |
| 2019 Q4 | -30.78 Million USD | -11.76% |
| 2019 FY | - USD | -65.87% |
| 2019 Q3 | -27.54 Million USD | -7.98% |
| 2019 Q2 | -25.5 Million USD | -14.66% |
| 2019 Q1 | -22.24 Million USD | -23.52% |
| 2018 Q1 | -15.32 Million USD | 0.45% |
| 2018 Q2 | -15.09 Million USD | 1.49% |
| 2018 FY | - USD | -20.43% |
| 2018 Q3 | -15.51 Million USD | -2.79% |
| 2018 Q4 | -18.01 Million USD | -16.06% |
| 2017 FY | - USD | -35.77% |
| 2017 Q3 | -12.98 Million USD | 0.0% |
| 2017 Q4 | -15.39 Million USD | -18.59% |
| 2016 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -117.56 Million USD | -50.304% |
| Applied DNA Sciences, Inc. | -9.59 Million USD | -1742.396% |
| Aspira Women's Health Inc. | -16.49 Million USD | -971.524% |
| Biodesix, Inc. | -37.1 Million USD | -376.255% |
| BioNexus Gene Lab Corp. | -2.48 Million USD | -7010.405% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -2216.135% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -2216.135% |
| Bionano Genomics, Inc. | -213.6 Million USD | 17.274% |
| CareDx, Inc | -89.65 Million USD | -97.09% |
| Check-Cap Ltd. | -17.64 Million USD | -901.218% |
| Castle Biosciences, Inc. | -45.02 Million USD | -292.468% |
| DarioHealth Corp. | -53.49 Million USD | -230.327% |
| Exact Sciences Corporation | 41.87 Million USD | 521.972% |
| Fulgent Genetics, Inc. | -46.55 Million USD | -279.586% |
| Guardant Health, Inc. | -433.3 Million USD | 59.219% |
| ICON Public Limited Company | 1.63 Billion USD | 110.83% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | 114.512% |
| Illumina, Inc. | -608 Million USD | 70.937% |
| Intelligent Bio Solutions Inc. | -8.81 Million USD | -1905.571% |
| iSpecimen Inc. | -9.1 Million USD | -1841.02% |
| Standard BioTools Inc. | -54.45 Million USD | -224.485% |
| MDxHealth SA | -30.46 Million USD | -479.969% |
| 23andMe Holding Co. | -291.87 Million USD | 39.458% |
| Medpace Holdings, Inc. | 363.15 Million USD | 148.659% |
| Myriad Genetics, Inc. | -67.8 Million USD | -160.627% |
| Mainz Biomed B.V. | -25.01 Million USD | -606.503% |
| ENDRA Life Sciences Inc. | -9.78 Million USD | -1705.913% |
| NeoGenomics, Inc. | -17.6 Million USD | -903.607% |
| Neogen Corporation | 182.59 Million USD | 196.773% |
| Inotiv, Inc. | -26.5 Million USD | -566.66% |
| Natera, Inc. | -383.27 Million USD | 53.896% |
| OpGen, Inc. | -29.51 Million USD | -498.777% |
| OPKO Health, Inc. | -65.51 Million USD | -169.713% |
| Psychemedics Corporation | -251 Thousand USD | -70300.398% |
| Prenetics Global Limited | -47.89 Million USD | -268.934% |
| Prenetics Global Limited | -47.89 Million USD | -268.934% |
| Precipio, Inc. | -4.31 Million USD | -3992.288% |
| Personalis, Inc. | -96.8 Million USD | -82.533% |
| RadNet, Inc. | 292.78 Million USD | 160.353% |
| Sera Prognostics, Inc. | -35.28 Million USD | -400.765% |
| Sotera Health Company | 514.14 Million USD | 134.369% |
| Neuronetics, Inc. | -22.75 Million USD | -676.418% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -10374.511% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -10374.511% |
| Trinity Biotech plc | -24.09 Million USD | -633.277% |
| T2 Biosystems, Inc. | -43.87 Million USD | -302.746% |
| Exagen Inc. | -19.15 Million USD | -822.597% |